Authors: Scott Taylor Robin J Heinrichs Jeff M Janzen As’ad Ehtisham
Publish Date: 2010/10/02
Volume: 15, Issue: 1, Pages: 80-84
Abstract
To date common therapy in patients with intracranial hemorrhage ICH includes prophylaxis of seizure using antiepileptic drugs commonly phenytoin Phenytoin therapy is associated with a high incidence of cognitive disturbance Levetiracetam is known to cause less cognitive disruption and may be a suitable alternative for seizure prophylaxis Cognitive outcomes in ICH patients receiving seizure prophylaxis with levetiracetam or phenytoin are comparedStatistically significant results included higher Glasgow Coma Scores GCS at dismissal median 14 vs 11 P = 0023 lower seizure incidence 00 vs 8 P = 003 for patients receiving levetiracetam than those treated with phenytoin and patients being discharged home 217 vs 16 P = 003 Observed trends included greater cognitive function retention rate 567 vs 36 P = 008Despite similarities in hemorrhage type and severity at onset patients receiving levetiracetam had better cognition at discharge and fewer seizures than patients receiving phenytoin These data suggest that levetiracetam is more effective than phenytoin for seizure prophylaxis without suppression of cognitive abilities in patients with ICH
Keywords: